Chart of the day

How does policy uncertainty affect the stock market?  (Capital Spectator)


It’s been a while since S&P 500 stocks have been oversold.  (@jackdamn)

Three approaches to volatility.  (research puzzle pix)

The risk on/risk off trade and the forex markets.  (FT Alphaville)

How some traders are taking on the algorithms.  (FT)


The seven deadly sins of trading.  (Brian Lund)

Don’t get too hung up on any particular low volatility methodology.  (Falkenblog)

There are no guarantees in a 60/40 portfolio.  (SmartMoney)

Narrowly defined ETFs blur the distinction between passive and active investing.  (FirstBridgeData)


On the myth of the imperial CEO.  (FT)

How times have changed: Sony’s ($SNE) market cap is only 3% of Apple ($AAPL).  (FT)

How companies are stressing efficiency: the case of 3M ($MMM).  (WSJ)

Warren Buffett doubles down on the newspaper business.  (Dealbook, Bloomberg)

Private companies pay more on their bonds than comparable public companies.  (Liberty Street Economics)


A profile of Covestor.  (onwallstreet)

What is Personal Capital up to?  (TechCrunch)

Technology companies have once again discovered the importance of the human touch.  (Pando Daily

Hedge funds

Canadian Pacific ($CP) caves to Bill Ackman.  (Dealbook, Clusterstock, Globe and Mail)

Big name hedge fund types, like David Einhorn, can have a big effect on stocks these days.  (Crossing Wall Street, Kid Dynamite)

Herbalife ($HLF) lives!  (Kid Dynamite)

Greenlight Re ($GLRE) is trading near book value.  (The Brooklyn Investor)


Money is fleeing Greece.  (The Reformed Broker)

More signs that Argentina has gone rogue and people are dumping pesos.  (Sober Look)

Then again one hedge fund manager is buying Argentinian debt.  (Deal Journal)


Weekly initial unemployment claims come in pretty much in line.  (Capital Spectator, Calculated Risk)

The Philly Fed Index comes in weak.  (Calculated Risk)

Leading economic indicators turn negative.  (EconomPic Data)

Earlier on Abnormal Returns

The ultimate Facebook IPO linkfest: part two.  (Abnormal Returns)

What you missed in our Thursday morning linkfest.  (Abnormal Returns)

Good news, bad news

Maybe good cholesterol isn’t all that good.  (NYTimes)

Good news: coffee helps you live longer.  (Bloomberg)

Abnormal Returns is a founding member of the StockTwits Blog Network.

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Please see disclosures here.

Please see the Terms & Conditions page for a full disclaimer.